找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Urologic Oncology; Multidisciplinary Ca Kelly L. Stratton,Alicia K. Morgans Book 2022 The Editor(s) (if applicable) and The Author(s), unde

[复制链接]
查看: 18587|回复: 60
发表于 2025-3-21 16:33:50 | 显示全部楼层 |阅读模式
书目名称Urologic Oncology
副标题Multidisciplinary Ca
编辑Kelly L. Stratton,Alicia K. Morgans
视频video
概述Illuminates the benefits of multidisciplinary co-management.Emphasizes the upcoming expansion of new therapeutics for urologic malignancies.Written by leading experts in the practice of team-based uro
图书封面Titlebook: Urologic Oncology; Multidisciplinary Ca Kelly L. Stratton,Alicia K. Morgans Book 2022 The Editor(s) (if applicable) and The Author(s), unde
描述Urologists and medical oncologists have witnessed a rapid growth in systemic therapeutic options for treating genitourinary malignancies that increasingly integrates radiation therapy to primary cancers, nodal beds, and even metastatic sites. The culmination of these advances has been the creation of multidisciplinary teams that expertly provide comprehensive care to patients with urologic cancers. This book provides the framework to create such a multidisciplinary clinical team focused on the treatment of urologic malignancies with representation from urologists, medical oncologists, and additional specialists who work together to provide optimal team-based care. The book integrates advanced systemic therapeutics including immune-based and targeted therapies. Readers gain a better understanding of the benefit of multidisciplinary co-management through specific examples such as hormone sensitive metastatic prostate cancer, neoadjuvant chemotherapy for muscle invasive bladdercancer, and immunotherapy approaches to advanced bladder and kidney cancer. The book also discusses the integration of genomic tumor characterization and personalized medicine into surgical planning, tumor biops
出版日期Book 2022
关键词genitourinary malignancy; team-based care; prostate cancer; bladder cancer; kidney cancer
版次1
doihttps://doi.org/10.1007/978-3-030-89891-5
isbn_softcover978-3-030-89893-9
isbn_ebook978-3-030-89891-5
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Urologic Oncology影响因子(影响力)




书目名称Urologic Oncology影响因子(影响力)学科排名




书目名称Urologic Oncology网络公开度




书目名称Urologic Oncology网络公开度学科排名




书目名称Urologic Oncology被引频次




书目名称Urologic Oncology被引频次学科排名




书目名称Urologic Oncology年度引用




书目名称Urologic Oncology年度引用学科排名




书目名称Urologic Oncology读者反馈




书目名称Urologic Oncology读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:18:26 | 显示全部楼层
Creating a Multidisciplinary Clinic,Multidisciplinary clinics (MDCs) have emerged as a strategy to simplify the process for patients and provide a forum for clinicians of different disciplines to evaluate and discuss patient care in real time. This has led to improved patient satisfaction and outcomes. There is no universal definition
发表于 2025-3-22 02:06:47 | 显示全部楼层
发表于 2025-3-22 05:23:47 | 显示全部楼层
发表于 2025-3-22 11:32:09 | 显示全部楼层
High-Risk Localized Prostate Cancer,calized curable tumors to men with occult metastatic potentially incurable tumors. Therefore, risk stratification, judicious use of imaging, and integration of multimodality therapy are necessary to achieve optimal survival. Clinicians must have familiarity with the full spectrum of management strat
发表于 2025-3-22 13:58:05 | 显示全部楼层
Treatment of Metastatic Hormone-Sensitive Prostate Cancer,d ability to detect men with metastatic disease still in the hormone-sensitive space has altered the standard of care for advanced prostate cancer..: To describe the biologic basis, evidence, and rationale for use of available treatments for men with metastatic hormone-sensitive prostate cancer (mHS
发表于 2025-3-22 17:29:36 | 显示全部楼层
Expanding Options for M0 Castration-Resistant Prostate Cancer (CRPC),tinuously exposed to castration levels of androgen deprivation therapy (ADT), but in whom no radiographic evidence of metastatic disease can be identified. Prior to 2018, observation with or without the initiation of first-generation anti-androgen therapy or clinical trial enrollment was the guideli
发表于 2025-3-23 00:33:08 | 显示全部楼层
发表于 2025-3-23 02:08:19 | 显示全部楼层
Advances in Prostate Cancer Imaging,es, in part, the purpose of staging and risk-stratifying patients to formulate the most effective treatment plan with the least adverse side effects. However, traditional imaging techniques could only serve this role with significant limitations. Computed tomography (CT), for instance, has a size cr
发表于 2025-3-23 06:59:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-21 20:27
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表